Research Article
Exercise Therapy for Management of Type 2 Diabetes Mellitus: Superior Efficacy of Activity Monitors over Pedometers
Table 1
Clinical characteristics of the activity monitor group and pedometer group.
| | | Activity monitor group () | Pedometer group () | value |
| | Age (years) | 62.7 ± 9.2 | 62 ± 10.6 | 0.97 | | Male | 78.3% | 56.8% | <0.005 | | Height (m) | 1.63 ± 0.08 | 1.62 ± 0.09 | 0.12 | | Weight (kg) | 72.6 ± 15.7 | 69.1 ± 15.4 | 0.11 | | BMI | 27.2 ± 5.1 | 26.4 ± 5.4 | 0.21 | | HbA1c (%) | 7.1 ± 1.1 | 7.0 ± 1.2 | 0.53 | | Systolic BP (mmHg) | 122.8 ± 11.1 | 123.0 ± 10.9 | 0.98 | | Diastolic BP (mmHg) | 70.9 ± 9.3 | 71.9 ± 9.5 | 0.79 | | UA (mg/dL) | 6.0 ± 1.5 | 5.3 ± 1.3 | <0.005 | | HDL cholesterol (mg/dL) | 59.9 ± 17.2 | 60.9 ± 19.7 | 0.85 | | LDL cholesterol (mg/dL) | 108.7 ± 24.9 | 112.0 ± 23.9 | 0.60 | | Triglycerides (mg/dL) | 151.1 ± 103.8 | 138.3 ± 75.9 | 0.49 |
|
|
Values are mean ± SD.
BMI: body mass index; BP: blood pressure; UA: uric acid; HDL: high-density lipoprotein; LDL: low-density lipoprotein.
|
